Table 1

Characteristics of the Study Population According to the First High-Sensitivity Cardiac Troponin T Level

CharacteristicsAll Patients (N = 14,636)High-Sensitivity Cardiac Troponin T Level (ng/l)
<5 (n = 8,907)5–14 (n = 3,150)>14 (n = 2,579)
Percentage of study population100612118
Age, yrs55 ± 1947 ± 1563 ± 1671 ± 15
Female, %48534137
eGFR
 >60 ml/min/1.73 m2, %88988557
 30–60 ml/min/1.73 m2, %102.41532
 15–30 mL/min/1.73 m2, %2.10.030.7411
eGFR, ml/min/1.73 m290 ± 2599 ± 1882 ± 2165 ± 28
Diabetes mellitus, %9.54.71421
COPD, %3.41.65.07.6
Previous MI, %8.541221
Previous stroke, %4.92.1713
Previous hospital stay for CHF, %5.71.47.319
Aspirin, %199.73040
Beta-blockers, %23133647
ACE/ARB, %24133546
Statins, %19112834

Values are % or mean ± SD.

ACE/ARB = angiotensin-converting enzyme inhibitor/angiotensin-receptor blocker. CHF = congestive heart failure; COPD = chronic obstructive pulmonary disease; eGFR = estimated glomerular filtration rate; MI = myocardial infarction.